Mycobacterium haemophilum: a challenging treatment dilemma in an immunocompromised patient

Cutis. 2019 Sep;104(3):E7-E10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Immunocompromised Host*
  • Leukemia, Myeloid, Acute / immunology*
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Middle Aged
  • Mycobacterium Infections / drug therapy*
  • Mycobacterium haemophilum / isolation & purification*
  • Mycobacterium haemophilum / pathogenicity
  • Skin Diseases, Bacterial / drug therapy*
  • Stem Cell Transplantation / adverse effects

Substances

  • Anti-Bacterial Agents